ViiV Healthcare teams up with MPP to license patents related to HIV drug cabotegravir
ViiV Healthcare and MPP are actively negotiating on terms of a voluntary licensing agreement, which would help widen…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 May 22
ViiV Healthcare and MPP are actively negotiating on terms of a voluntary licensing agreement, which would help widen…
26 May 22
The company intends to begin delivering the monkeypox vaccine immediately to facilitate a rapid response to the current…
23 May 22
Fosun Pharma will obtain an exclusive license to VerImmune’s lead AIR-ViP product candidate, VERI-101, in Mainland China, Hong…
18 May 22
AstraZeneca will obtain an exclusive global licence to develop, manufacture and commercialise pre-clinical Covid-19 antibodies engineered by RQ…
17 May 22
Chimerix is expected to receive $225m as a one-time upfront payment and is eligible to receive a total…
13 May 22
BBP-398 is an inhibitor of SHP2 and was founded through a partnership with the Therapeutics Discovery division of…
11 May 22
CEPI will provide up to $19.3m funding to an international multidisciplinary consortium comprising India’s Bharat Biotech International (BBIL),…
10 May 22
Sunosi is indicated to improve wakefulness in adult patients suffering from excessive daytime sleepiness (EDS) due to narcolepsy…
09 May 22
The company intends to use the proceeds from the funding to ramp up the ongoing clinical trials of…
09 May 22
Orion will pay an upfront payment of €15m to Jemincare, in addition to certain development, commercialisation and sales…